A Phase 1, Multicompartmental Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Cabotegravir (Primary) ; Cabotegravir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 10 Aug 2017 Planned End Date changed from 1 Dec 2017 to 7 Aug 2018.
- 10 Aug 2017 Planned primary completion date changed from 1 Dec 2017 to 7 Aug 2018.
- 10 Aug 2017 Status changed from not yet recruiting to recruiting.